the roles of irb investigators in clinical research
Download
Skip this Video
Download Presentation
The Roles of IRB & Investigators in Clinical Research

Loading in 2 Seconds...

play fullscreen
1 / 44

The Roles of IRB Investigators in Clinical Research - PowerPoint PPT Presentation


  • 204 Views
  • Uploaded on

The Roles of IRB & Investigators in Clinical Research. Definitions. IRB : A specially constituted review body established or designated by an entity to protect the welfare of human subjects recruited to participate in biomedical or behavioral research.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'The Roles of IRB Investigators in Clinical Research' - luana


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
definitions
Definitions

IRB: A specially constituted review body established or designated by an entity to protect the welfare of human subjects recruited to participate in biomedical or behavioral research.

RESEARCH: A systematic investigation, including research development, testing and evaluation, designed to develop or contribute to generalizable knowledge.

HUMAN SUBJECTS: A living individual about whom an investigator conducting research obtains data through intervention or interaction with the individual, or identifiable private information.

landmark document
Landmark Document
  • The Nuremburg Code

Permissible Medical Experiments” Trials of War Criminals before

the Nuermberg Military Tribunals under Control Council Law No.

10, 1949

  • Helsinki Declaration

World Medical Association General Assembly, Edinburgh,

Scotland, October 2000

  • Belmont Report of 1979

Report of the National Commission for the Protection of Human

Subjects ot Biomedical and Behavioral Research, DHEW, April

1979

slide4

The federal regulations are intended to implement the basic ethical principles governing the conduct of human research. These ethical principles are set forth in the Belmont Report. No one should be involved in human research at any level without being familiar with these ethical principles.

policies cited from the cfr
Policies Cited from the CFR

Citation Title

21 CFR 50 FDA - Protection of Human Subjects, Informed Consent

21 CFR 56 FDA - Institutional Review Boards

45 CFR 46, Subpart A DHHS - Basic Policy for Protection of Human Research Subjects (Common Rule)

45 CFR 46, Subpart B DHHS - Research Involving Fetuses, Pregnant Women, and Human In Vitro Fertilization

45 CFR 46, Subpart C DHHS - Additional Protection for Children Involved as Subjects in Research

45 CFR 46, Subpart D DHHS - Additional Protections Pertaining to Research Involving Prisoners as Subjects

differences between fda and dhhs regulations
Differences BetweenFDA and DHHS Regulations
  • The basic requirements for IRBs and for Informed Consent are congruent between the two sets of regulations. Differences center on differences in applicability:
  • The Common Rule applies to all research involving human subjects conducted, supported by any federal department or agency.
  • FDA regulations are applied primarily to use of FDA regulated products: drugs, devices, or biologics.
institutional review boards
Institutional Review Boards

CODE OF FEDERAL REGULATIONS

TITLE 45PUBLIC WELFARE

DEPARTMENT OF HEALTH AND HUMAN SERVICESNATIONAL INSTITUTES OF HEALTHOFFICE FOR PROTECTION FROM RESEARCH RISKS

PART 46PROTECTION OF HUMAN SUBJECTS

* * *

Revised June 18, 1991Effective August 19, 1991

slide8

§46.108 IRB functions and operations

In order to fulfill the requirements of this policy each IRB shall:

(a) Follow written procedures in the same detail as described in 46.103 (b)(4) and to the extent required by 46.103 (b)(5).

(b) Except when an expedited review procedure is used review proposed research at convened meetings at which a majority of the members of the IRB are present, including at least one member whose primary concerns are in nonscientific areas. In order for the research to be approved, it shall receive the approval of a majority of those members present at the meeting

irb responsibilities
IRB Responsibilities
  • Conducting initial review
  • Conducting continuing review
  • Notifying the investigators about IRB decisions
  • Determining which studies require review more

often than annually

  • Review and approval of changes in research

activities

  • Determining which device studies pose

significant or non-significant risk

irb responsibilities cont
IRB Responsibilities (Cont.)
  • Ensuring that changes in approved research are not initiated without IRB review and approval except where necessary to eliminate apparent immediate hazards
  • Ensuring prompt reporting to appropriate institutional officials, regulatory agencies and funding sources of:
    • unanticipated problems involving risks to subjects or others
    • serious or continuing noncompliance with federal regulations
    • suspension or termination of IRB approval
irb authority
IRB Authority
  • The IRB reviews, and has the authority to approve, require modification in, or disapprove all research activities, including proposed changes in ongoing, previously approved, human subject research.
  • The IRB has the authority to suspend or terminate the approval of ongoing, previously approved research that is not being conducted in accordance with the IRB\'s requirements or that has been associated with unexpected, serious harm to subjects.
continuing review
Continuing Review
  • The IRB conducts continuing review of ongoing, approved research at intervals appropriate to the degree of risk, but not less than once per year.
  • For approved research, the IRB determines which activities require continuing review more frequently than every twelve months.
  • Continuing IRB reviews are preceded by receipt of appropriate progress reports from the investigator, including available, study-wide findings.
  • Continuing review must be substantive and meaningful.
irb membership
IRB Membership
  • At least 5 members
    • at least one scientist and one lay person
  • Sufficiently qualified through experience and expertise
  • Diversity
criteria for irb approval
Criteria for IRB Approval
  • Risks to subjects are minimized
  • Risks are reasonable in relation to anticipated benefits
  • Selection of subjects is equitable
  • Informed consent is sought from each subject
  • Informed consent is appropriately documented.
additional criteria where appropriate
Additional Criteria Where Appropriate
  • Data collection is monitored to ensure subject safety
  • Privacy and confidentiality of subjects is protected
  • Additional safeguards are included for vulnerable populations.
expedited review
Expedited Review
  • Some specified categories of minimal risk research may be reviewed by the IRB through an expedited review procedure.
  • Expedited review may be carried out by the IRB chair or by one or more designated IRB members.
  • All of the requirements for IRB approval of research apply equally to expedited review. Expedited review should not be viewed as a less rigorous review.
  • Under expedited review, the reviewers may exercise all of the authorities of the IRB, except that the reviewers may not disapprove the research.
expedited review procedures may be used for
Expedited review procedures may be used for-
  • Research appearing on the list and found by the reviewer to involve no more than minimal risk
  • Minor changes in previously approved research during the authorized approval period of one years or less.
important considerations
Important Considerations
  • IRB’s responsibility is the protection of human subjects
  • IRB activity is governed by a strict set of regulations with oversight from the Office for Research Protection (OPRR)
requirements for irb convened meetings
Requirements for IRB Convened Meetings
  • a majority of the members of the IRB must be present and at least one nonscientist must be present
  • if the required number of members is lost during a meeting, no action may be taken until it is restored
  • in order for research to be approved, it must receive the approval of a majority of those members present at the meeting
irb minutes
IRB Minutes
  • Minutes of IRB meetings must include:
  • attendance at the meetings
  • actions taken by the IRB
  • the vote on these actions including the number of members voting for, against, and abstaining
  • the basis for requiring changes in or disapproving research
  • documentation of specific findings required by the regulations, and
  • a written summary of the discussion of debated issues and their resolution
irb records
IRB Records
  • copies of all research proposals reviewed, scientific evaluations, if any, that accompany the proposals, approved sample consent documents, progress reports submitted by investigators, and reports of injuries to subjects;
  • minutes of IRB meetings;
  • records of continuing review activities;
  • copies of all correspondence between the IRB and the investigators;
  • a list of IRB members;
  • written procedures for the IRB
  • statements of significant new findings provided to subjects
important considerations22
Important Considerations
  • IRB is NOT responsible for fostering of research
  • Regulations are vague and subject to collective interpretation of the IRB members
  • IRB members review protocols outside of their area of expertise
    • protocols must be clear and understandable
important considerations23
Important Considerations
  • Protocols are usually reviewed by two members
    • usually one with expertise/experience
    • one with general knowledge
  • IRB submission is NOT an NIH grant nor is it a submission to the FDA
  • Lack of scientific merit renders a protocol unethical
irb initial review
IRB Initial Review

The process of protocol review and approval not only improves the protection of research participants, it improves the research itself.

The IRB is a speed bump on my road to progress.

IRB

P.I.

continuing review25
Continuing Review

The progress report is just one more opportunity for the IRB to obstruct my research.

Continuing review of every protocol is an important component of human subject protections.

IRB

P.I.

adverse events reporting
Adverse Events Reporting

Give me a break! What does the IRB know about adverse events?

An IRB must be made aware of adverse events - this is the only way to provide continuing assessment of the risks and potential benefits of the study.

IRB

P.I.

the relationship between the investigator and the irb
The Relationship Between the Investigator and the IRB

The IRB

Finally!

Have a nice trip! See you next time!!

The P.I.

the relationship between the investigator and the irb28
The Relationship Between the Investigator and the IRB

Here’s a phone card, call to check in. Call immediately if something bad happens. If we don’t hear from you, your trip is cancelled!

What!

The P.I.

The IRB

the relationship between the investigator and the irb29
The Relationship Between the Investigator and the IRB

And remember… plan to get together a few times during your trip.

Oh joy!

The IRB

The P.I.

investigators responsibilities
Investigators’ Responsibilities
  • Regulatory Documentation
  • IRB Correspondence
  • Informed Consent Process
  • Recruitment Procedures
  • Subject Selection Criteria
  • SAE Reporting
  • Drug/Device Accountability
  • CRF/Source Documentation
  • Record Keeping
  • Allocation of Responsibilities
regulatory documentation
Protocol

FDA 1572, 1571

CVs

Enrollment log

Monitoring log

Staff signature log

IB or DM

Copy of normal lab values

Lab Certification

Clinical Investigator Financial Disclosure form

All correspondence to and from sponsor and/or FDA

Regulatory Documentation
irb documentation
IRB Documentation
  • All correspondence (e.g. e-mails, submission…) between investigators /study staff and HRC
  • IRB Initial approval
  • IRB continuing review
  • Amendments
  • Violations/deviations (including sponsor-approved protocol deviations)
recruitment procedures
Recruitment Procedures
  • Recruitment methods stated in the protocol
  • Identify potential subjects
  • Make initial contact
  • Recruitment material
  • IRB approval
informed consent process
Informed Consent Process
  • IRB approval
  • Different versions (expiration date)
  • Investigator sign and date consent form
  • Subject sign and date consent form
  • Copy to subjects
subject selection criteria
Subject Selection Criteria
  • Eligibility checklist
  • Signature/initials and date
  • Protocol deviation
adverse event reporting
Adverse Event Reporting
  • Institution/sponsor guidelines vs. Federal Regulations
  • Interventional vs. non-interventional
  • Serious vs. Non-serious
drug dispensing and crf
Drug/Device Dispensing

Accountability:

Dispensing log

Shipping/receiving

CRF/SD:

Consistency

Dated signature /initials

Cross-outs

Drug Dispensing and CRF
record keeping
Record Keeping
  • Regulatory binder/folder
  • IRB Binder/folder
  • Study file for EACH subject
allocation of responsibilities
Allocation of Responsibilities
  • Initial submission
  • Progress report for continuing review
  • SAE/AE reporting
  • Obtaining informed consent
handling non compliance
Handling Non-Compliance
  • Reporting
  • Note to File
  • Corrective Actions
  • Follow-up
common findings
Common Findings

1. Source Documentation

2. Lab Documentation

3. Investigator Brochure

4. NIH Progress Report/DSMB

5. Curriculum Vitae (CVs)

6. Study Logs

7. Eligibility Criteria Checklist

8. Consent Form Issues

9. Protocol deviations, violations

10. Record Keeping

helpful websites
Helpful Websites
  • FDA - http:// www.fda.gov
  • NIH - http:// www.nih.gov
  • OHRP- http://ohrp.osophs.dhhs.gov
  • FDA IRB Guidance document - http:// www.fda.gov/oc/oha/IRB/toc.html
  • Code of Federal Regulations - http:// www.access.gpo.gov/nara/cfr/cfr-table-search.html
helpful websites cont
Helpful Websites (Cont.)
  • OHRP Compliance Oversight
    • http://ohrp.osophs.dhhs.gov/compovr.htm
  • OHRP Compliance Findings & Guidance
    • http://ohrp.osophs.dhhs.gov/references/findings.pdf
  • OHRP Education Materials
    • http://ohrp.osophs.dhhs.gov/educmat.htm
  • FDA Warning Letters
    • www.fda.gov/foi/warning.htm
helpful websites cont44
Helpful Websites (Cont.)
  • FDA Information Sheets
    • http://www.fda.gov/oc/oha/irb/toc3.html#contreview
  • FDA MedWatch (AE Reporting)
    • http://www.fda.gov/medwatch/report/desk/tpcfinal.htm#toc
  • PRIM&R
    • http://www.primr.org/
  • Bioethics Resources
    • http://www.nih.gov/sigs/bioethics/
ad